Cryoprecipitate Dosing for Fibrinogen Replacement

ورودی‌های بالینی بیمار

حداقل ۱ — حداکثر ۳۰۰ • واحد: kg

حداقل ۰.۱۵ — حداکثر ۰.۶۵ • واحد: decimal

حداقل ۰ — حداکثر ۱۰۰۰ • واحد: mg/dL

حداقل ۵۰ — حداکثر ۵۰۰ • واحد: mg/dL

حداقل ۱۵۰ — حداکثر ۳۰۰ • واحد: mg

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
units required
—units
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Low Dose1–5
  • Standard Dose6–15
  • High Dose16–30
  • Very High Dose31–100
Direct Clinical Answer

The Cryoprecipitate Dosing for Fibrinogen Replacement calculator is designed for bedside calculating the required dose of cryoprecipitate units needed to achieve target fibrinogen levels in patients with fibrinogen deficiency or hypofibrinogenemia in clinical practice. The resulting score directly guides clinician decision-making regarding initiating targeted anticoagulation.

Clinical Guidelines & Evidence

Calculates the required dose of cryoprecipitate units needed to achieve target fibrinogen levels in patients with fibrinogen deficiency or hypofibrinogenemia

Clinical Indication

The Cryoprecipitate Dosing for Fibrinogen Replacement is indicated for bedside clinical practice to support Calculates the required dose of cryoprecipitate units needed to achieve target fibrinogen levels in patients with fibrinogen deficiency or hypofibrinogenemia. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with coagulopathy, thrombocytopenia, venous thromboembolism (DVT/PE), or hematologic neoplasms. Clinical application is indicated across Hematology-oncology services, bone marrow transplant units, anticoagulation clinics, and acute medical wards.

Limitations & Contraindications

Severe thrombocytopenia with concomitant microvascular thrombosis (TTP, HIT, DIC) represents a medical emergency requiring rapid intervention.

Clinical Pearls & Action Plan

Detailed history of heparin exposure, platelet count kinetics, and comprehensive coagulation profiles are vital in consumptive coagulopathies.

Formula & Variables:

Required Units = (Target Fibrinogen - Current Fibrinogen) × Plasma Volume / Fibrinogen per Unit; where Plasma Volume (dL) = Weight (kg) × Factor × (1 - Hematocrit); Factor = 0.07 for males, 0.065 for females

Input Parameters

NameTypeRequiredDescription
patient_weightfloatYesPatient weight in kilograms(kg)
patient_sexstringYesPatient biological sex for plasma volume calculation
hematocritfloatYesCurrent hematocrit as decimal (e.g., 0.40 for 40%)(decimal)
current_fibrinogenfloatYesCurrent fibrinogen level(mg/dL)
target_fibrinogenfloatYesTarget fibrinogen level to achieve(mg/dL)
fibrinogen_per_unitfloatNoFibrinogen content per cryoprecipitate unit (default 200 mg)(mg)

Score Interpretation & Guidance

RangeStageDescription
1–5Low DoseSmall fibrinogen replacement
6–15Standard DoseTypical therapeutic replacement
16–30High DoseLarge fibrinogen replacement
31–100Very High DoseMassive fibrinogen replacement

Evidence-Based References (EBM)

  • American Association of Blood Banks (AABB). Technical Manual, 20th Edition. 2020.
  • British Committee for Standards in Haematology (BCSH). Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol. 2004;126(1):11-28.
  • Stanworth SJ, Brunskill SJ, Hyde CJ, McClelland DB, Murphy MF. Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. Br J Haematol. 2004;126(1):139-152.
  • American Red Cross. Circular of Information for the Use of Human Blood and Blood Components. 2017.

Related calculators